Observational studyPloS one2022

Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog.

Yoshihito Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.